他噴他多市場：用途（咳嗽治療、疼痛管理）、最終用戶（診所、醫院、藥房）分類 - 全球預測 2023-2030 年

他噴他多的全球市場預計將顯著成長，預計2023年將達到38.6404億美元，年複合成長率為6.36%，2030年將達到59.5884億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球他噴他多市場至關重要。透過檢驗業務策略和產品滿意度等關鍵指標，它可以對供應商進行全面評估，使用戶能夠根據自己的特定需求做出資訊的決策。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發地區、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1.他噴他多的全球市場規模和預測是多少？

2.在預測期內，COVID-19對全球他噴他多市場的阻礙因素與影響為何？

3. 在預測期內，全球他噴他多市場需要投資哪些產品/細分市場/應用/領域？

4.他噴他多在全球市場的競爭策略是什麼？

5. 全球他噴他多市場的技術趨勢和法律規範是什麼？

6. 全球他噴他多市場主要供應商的市佔率是多少？

7.他噴他多適合以什麼樣的型態和策略舉措進入全球市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

• 市場動態
  • 促進因素
    • 慢性肌肉骨骼疼痛的高發生率
    • 對非處方止痛藥的需求不斷成長
    • 糖尿病盛行率增加，止痛藥需求增加
  • 抑制因素
    • 他噴他多相關的副作用
  • 機會
    • 治療和治療方法開發的進展
    • 透過網路藥局可大量獲得
  • 任務
    • 嚴格的政府法規和替代品的可用性
• 市場趨勢
• COVID-19 的累積影響
• 俄羅斯-烏克蘭衝突的累積影響
• 高通膨的累積效應
• 波特五力分析
• 價值鍊和關鍵路徑分析
• 法律規範
• 客戶客製化

第6章 他噴他多市場：按用途

• 咳嗽治療
• 疼痛管理
  • 癌症痛
  • 神經性疼痛

第7章 他噴他多市場：依最終用戶分類

• 診所
• 醫院
• 藥局

第8章 北美和南美他噴他多市場

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美國

第9章 亞太地區他噴他多市場

• 澳洲
• 中國
• 印度
• 印尼
• 日本
• 馬來西亞
• 菲律賓
• 新加坡
• 韓國
• 台灣
• 泰國
• 越南

第10章 歐洲、中東和非洲他噴他多市場

• 丹麥
• 埃及
• 芬蘭
• 法國
• 德國
• 以色列
• 義大利
• 荷蘭
• 奈及利亞
• 挪威
• 波蘭
• 卡達
• 俄羅斯
• 沙烏地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公國
• 英國

第11章競爭形勢

• FPNV定位矩陣
• 市佔率分析：主要企業
• 競爭情境分析：主要企業

第12章上市公司名單

第13章附錄

• 討論指南
• 關於許可證和定價

The Global Tapentadol Market is forecasted to grow significantly, with a projected USD 3,864.04 million in 2023 at a CAGR of 6.36% and expected to reach a staggering USD 5,958.84 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Tapentadol Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Tapentadol Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Application, market is studied across Cough Treatment and Pain Management. The Pain Management is further studied across Cancer Pain and Neuropathic Pain. The Cough Treatment is projected to witness significant market share during forecast period.

Based on End User, market is studied across Clinic, Hospital, and Pharmacy. The Pharmacy is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Tapentadol Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Tapentadol Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Tapentadol Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Tapentadol Market?

4. What is the competitive strategic window for opportunities in the Global Tapentadol Market?

5. What are the technology trends and regulatory frameworks in the Global Tapentadol Market?

6. What is the market share of the leading vendors in the Global Tapentadol Market?

7. What modes and strategic moves are considered suitable for entering the Global Tapentadol Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Tapentadol Market, by Application, 2022 vs 2030
• 4.3. Tapentadol Market, by End User, 2022 vs 2030
• 4.4. Tapentadol Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. High occurrence of chronic musculoskeletal pain
    • 5.1.1.2. Rising demand for over-the-counter painkillers
    • 5.1.1.3. Escalating prevalence of diabetes and increasing need for analgesics
  • 5.1.2. Restraints
    • 5.1.2.1. Side effects associated with tapentadol
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancement in treatment and therapeutics development
    • 5.1.3.2. Exponential availability through online pharmacies
  • 5.1.4. Challenges
    • 5.1.4.1. Strict government regulations and availability of substitute
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Tapentadol Market, by Application

• 6.1. Introduction
• 6.2. Cough Treatment
• 6.3. Pain Management
  • 6.3.1. Cancer Pain
  • 6.3.2. Neuropathic Pain

7. Tapentadol Market, by End User

• 7.1. Introduction
• 7.2. Clinic
• 7.3. Hospital
• 7.4. Pharmacy

8. Americas Tapentadol Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Tapentadol Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Tapentadol Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. FPNV Positioning Matrix
• 11.2. Market Share Analysis, By Key Player
• 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

• 13.1. Discussion Guide
• 13.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. TAPENTADOL MARKET RESEARCH PROCESS
• FIGURE 2. TAPENTADOL MARKET SIZE, 2022 VS 2030
• FIGURE 3. TAPENTADOL MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. TAPENTADOL MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
• FIGURE 5. TAPENTADOL MARKET SIZE, BY END USER, 2022 VS 2030 (%)
• FIGURE 6. TAPENTADOL MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 7. TAPENTADOL MARKET DYNAMICS
• FIGURE 8. TAPENTADOL MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 9. TAPENTADOL MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS TAPENTADOL MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. UNITED STATES TAPENTADOL MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. ASIA-PACIFIC TAPENTADOL MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. EUROPE, MIDDLE EAST & AFRICA TAPENTADOL MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. TAPENTADOL MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 15. TAPENTADOL MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. TAPENTADOL MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. TAPENTADOL MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 5. TAPENTADOL MARKET SIZE, BY COUGH TREATMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 7. TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. TAPENTADOL MARKET SIZE, BY CANCER PAIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. TAPENTADOL MARKET SIZE, BY NEUROPATHIC PAIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 11. TAPENTADOL MARKET SIZE, BY CLINIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. TAPENTADOL MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. TAPENTADOL MARKET SIZE, BY PHARMACY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. AMERICAS TAPENTADOL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 18. ARGENTINA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 19. ARGENTINA TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 20. ARGENTINA TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 21. BRAZIL TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 22. BRAZIL TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 23. BRAZIL TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 24. CANADA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. CANADA TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 26. CANADA TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 27. MEXICO TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. MEXICO TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 29. MEXICO TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 30. UNITED STATES TAPENTADOL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 31. UNITED STATES TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. UNITED STATES TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 33. UNITED STATES TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 34. ASIA-PACIFIC TAPENTADOL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 35. ASIA-PACIFIC TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. ASIA-PACIFIC TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 37. ASIA-PACIFIC TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 38. AUSTRALIA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. AUSTRALIA TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 40. AUSTRALIA TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 41. CHINA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. CHINA TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 43. CHINA TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 44. INDIA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. INDIA TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 46. INDIA TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 47. INDONESIA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. INDONESIA TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 49. INDONESIA TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 50. JAPAN TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. JAPAN TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 52. JAPAN TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 53. MALAYSIA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. MALAYSIA TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 55. MALAYSIA TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 56. PHILIPPINES TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. PHILIPPINES TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 58. PHILIPPINES TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 59. SINGAPORE TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. SINGAPORE TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 61. SINGAPORE TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 62. SOUTH KOREA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. SOUTH KOREA TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 64. SOUTH KOREA TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 65. TAIWAN TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. TAIWAN TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 67. TAIWAN TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 68. THAILAND TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. THAILAND TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 70. THAILAND TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 71. VIETNAM TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. VIETNAM TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 73. VIETNAM TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 74. EUROPE, MIDDLE EAST & AFRICA TAPENTADOL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 75. EUROPE, MIDDLE EAST & AFRICA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. EUROPE, MIDDLE EAST & AFRICA TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 77. EUROPE, MIDDLE EAST & AFRICA TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 78. DENMARK TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. DENMARK TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 80. DENMARK TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 81. EGYPT TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. EGYPT TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 83. EGYPT TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 84. FINLAND TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. FINLAND TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 86. FINLAND TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 87. FRANCE TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. FRANCE TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 89. FRANCE TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 90. GERMANY TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. GERMANY TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 92. GERMANY TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 93. ISRAEL TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. ISRAEL TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 95. ISRAEL TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 96. ITALY TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. ITALY TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 98. ITALY TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 99. NETHERLANDS TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. NETHERLANDS TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 101. NETHERLANDS TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 102. NIGERIA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. NIGERIA TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 104. NIGERIA TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 105. NORWAY TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. NORWAY TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 107. NORWAY TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 108. POLAND TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. POLAND TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 110. POLAND TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 111. QATAR TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. QATAR TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 113. QATAR TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 114. RUSSIA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. RUSSIA TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 116. RUSSIA TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 117. SAUDI ARABIA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. SAUDI ARABIA TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 119. SAUDI ARABIA TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 120. SOUTH AFRICA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. SOUTH AFRICA TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 122. SOUTH AFRICA TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 123. SPAIN TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. SPAIN TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 125. SPAIN TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 126. SWEDEN TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. SWEDEN TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 128. SWEDEN TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 129. SWITZERLAND TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. SWITZERLAND TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 131. SWITZERLAND TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 132. TURKEY TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. TURKEY TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 134. TURKEY TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 135. UNITED ARAB EMIRATES TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. UNITED ARAB EMIRATES TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 137. UNITED ARAB EMIRATES TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 138. UNITED KINGDOM TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. UNITED KINGDOM TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 140. UNITED KINGDOM TAPENTADOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 141. TAPENTADOL MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 142. TAPENTADOL MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 143. TAPENTADOL MARKET LICENSE & PRICING